Company / Current Assets per Share
BioNexus Gene Lab Corp Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.03
FY2025
5-year range
$0.04 / $3.03
FY2021-FY2025
Trend
+621.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +621% YoY in FY2025, a notable deviation from the 6-year average annual change of +429%.
Based on SEC 10-K filings.
3.03 in FY2025 with a 5-year CAGR of +108.1%.
Improved from $0.56 to $3.03 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +341.8%
- 5-Year CAGR
- +108.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share increased 621.1% year-over-year.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.03 | +621.1% |
| FY2024 | $0.42 | -24.3% |
| FY2023 | $0.56 | +1480.5% |
| FY2022 | $0.04 | -15.8% |
| FY2021 | $0.04 | -46.3% |
| FY2020 | $0.08 | +557.3% |
| FY2019 | $0.01 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026